Cargando…
DNA损伤修复与肺癌顺铂耐药机制的研究进展
Lung cancer is the most common cause of death from cancer worldwide per year.Platinum-based combination chemotherapy is a main treatment of lung cancer.Cisplatin is adopted widely and used effectively in the first-line chemotherapy.Unfortunately, development of cisplatin resistance is a major obstac...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000195/ https://www.ncbi.nlm.nih.gov/pubmed/22152698 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.12.11 |
Ejemplares similares
-
MicroRNA与肺癌顺铂耐药相关性研究进展
Publicado: (2014) -
DNA损伤修复系统与肺癌的药物治疗
Publicado: (2022) -
MiRNAs与EGFR-TKIs继发性耐药机制的研究进展
Publicado: (2015) -
铂类抗肿瘤药物相关肾损伤作用机制的研究进展
Publicado: (2015) -
P21参与肺癌耐药的研究进展
Publicado: (2020)